Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 10 min ago
Peer-reviewedCC BY 4.0European Journal of Nuclear Medicine and Molecular Imaging

The potential of [18F]FDG PET/MRI for identifying pain sources in patients with diagnostically challenging chronic hip pain after total hip replacement

  1. 1Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
  2. 2Department of Orthopaedics & Sports Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
  3. 3Department of Radiology, University of Wisconsin-Madison, Madison, WI USA

Abstract

Purpose: Chronic hip pain after total hip replacement (THR) poses a diagnostic challenge and frequently yields lengthy and unsatisfactory diagnostic work-up. This study aims to evaluate the diagnostic role and clinical impact of [18F]FDG PET/MRI compared with regular diagnostic work-up in patients with chronic hip pain after THR.

Methods: In this randomized study, 20 patients with persistent hip pain of unclear origin after THR underwent either PET/MRI-guided clinical management or regular diagnostic work-up. Additional diagnostic and therapeutic procedures during 12-month follow-up were recorded and a final expert diagnosis was determined through expert opinion based on all available information. Patient reported outcomes included pain scores, functional scores and quality of life.

Results: In the PET/MRI group, a final expert diagnosis could be established for 8/10 patients compared to 5/10 in the control group. PET-MRI contributed to this diagnosis in 7 of 10 patients by identifying 5 new pain sources, confirming 3 clinically suspected pain sources, and excluding 1 clinically suspected pain source. At 6 months, mean pain scores on NRS 0–10 decreased in both groups (PET/MRI: 6.1 to 5.2; control: 5.2 to 3.4). Between-group differences could not be statistically tested due to insufficient statistical power.

Conclusion: Initial results demonstrate the potential of [18F]FDG PET/MRI for the identification of pain sources in patients with diagnostically challenging chronic hip pain after THR. Further research regarding clinical outcome is warranted in a larger cohort with standardized treatment strategies incorporating PET/MRI findings.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s00259-026-08142-4.

Related

  1. Unexplained Optic Neuritis and New Heart Block: A Diagnostically Challenging Case of Probable Sarcoidosis.
    Chetan Kamath, Ghassan Al-Qaysi, Hemanta Paudel +2
    Clinical case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. A Tailored Sequencing Approach for Identifying SARS-CoV-2 Variants in Challenging Samples from Mink
    Aleksandra Giza, Ewelina Iwan, Arkadiusz Bomba +6
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Infectious diseaseCrossref
  3. Clinical practice guideline for renal replacement therapy in critically ill patients with acute kidney injury (2026 edition)
    Yan Kang, Xiangdong Guan, Dechang Chen
    Journal of intensive medicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Clinical Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Pure Native Aortic Regurgitation: A Systematic Review and Meta-Analysis
    Honghong Ke, Shirong Wang, Jinyi Li +1
    Journal of cardiovascular development and diseasePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Glucocorticoid replacement therapy and anthropometric features in patients with 21-hydroxylase deficiency in Japan: results from a nationwide epidemiological study
    Shigeru Suzuki, Kenichi Kashimada, Tokuo Mukai +5
    Endocrine JournalPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismJ-STAGE
BibTeX
@article{mostert2026potential,
  title = {{The potential of [18F]FDG PET/MRI for identifying pain sources in patients with diagnostically challenging chronic hip pain after total hip replacement}},
  author = {Jacob M. Mostert and Pieter K. Bos and Michael Ananta and Galied S. R. Muradin and Sandip Biswal and Edwin H.G. Oei and Rianne A. van der Heijden},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  month = aug,
  doi = {10.1007/s00259-026-08142-4},
  url = {https://doi.org/10.1007/s00259-026-08142-4},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The potential of [18F]FDG PET/MRI for identifying pain sources in patients with diagnostically challenging chronic hip pain after total hip replacement
AU  - Jacob M. Mostert
AU  - Pieter K. Bos
AU  - Michael Ananta
AU  - Galied S. R. Muradin
AU  - Sandip Biswal
AU  - Edwin H.G. Oei
AU  - Rianne A. van der Heijden
PY  - 2026
DA  - 2026/08/22
JO  - European Journal of Nuclear Medicine and Molecular Imaging
DO  - 10.1007/s00259-026-08142-4
UR  - https://doi.org/10.1007/s00259-026-08142-4
AB  - Purpose: Chronic hip pain after total hip replacement (THR) poses a diagnostic challenge and frequently yields lengthy and unsatisfactory diagnostic work-up. This study aims to evaluate the diagnostic role and clinical impact of [18F]FDG PET/MRI compared with regular diagnostic work-up in patients with chronic hip pain after THR.  Methods: In this randomized study, 20 patients with persistent hip pain of unclear origin after THR underwent either PET/MRI-guided clinical management or regular diagnostic work-up. Additional diagnostic and therapeutic procedures during 12-month follow-up were recorded and a final expert diagnosis was determined through expert opinion based on all available information. Patient reported outcomes included pain scores, functional scores and quality of life.  Results: In the PET/MRI group, a final expert diagnosis could be established for 8/10 patients compared to 5/10 in the control group. PET-MRI contributed to this diagnosis in 7 of 10 patients by identifying 5 new pain sources, confirming 3 clinically suspected pain sources, and excluding 1 clinically suspected pain source. At 6 months, mean pain scores on NRS 0–10 decreased in both groups (PET/MRI: 6.1 to 5.2; control: 5.2 to 3.4). Between-group differences could not be statistically tested due to insufficient statistical power.  Conclusion: Initial results demonstrate the potential of [18F]FDG PET/MRI for the identification of pain sources in patients with diagnostically challenging chronic hip pain after THR. Further research regarding clinical outcome is warranted in a larger cohort with standardized treatment strategies incorporating PET/MRI findings.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s00259-026-08142-4.
SN  - 1619-7070
SN  - 1619-7089
ER  -